A nurse smiling with a patient

Championing Quality Use of Medicines and better patient health outcomes

At CSL Behring we strive to identify and pursue new initiatives that address unmet medical and patient needs, improve and expand educational and outreach efforts.

The CSL Behring Grants Program supports the implementation of initiatives that foster knowledge and education, improves medication utilisation and delivery, ensuring the quality use of medicines drive better patient outcomes in hospital and the homecare setting.

If you would like to register your interest to apply for this Grant, please complete the following information.

* Mandatory fields

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

This Grants Program is for Australian Healthcare Professionals only.

If you do not wish to receive further information about CSL Behring products and services, please email customerservice@cslbehring.com.au and provide your name and contact information.

Privacy Notice: The personal information requested on this page will be used by CSL in connection with the CSL Behring grants program. If the requested information is not provided it may not be possible to process your application and communicate with you in relation to the status of your application. We may disclose your personal information to third parties including related companies and contractors engaged to provide services connected to this website. Some of these entities may be located outside of Australia or have their servers located outside Australia, which means your personal information may be transferred to the United States or countries within the European Union. For further information regarding CSL’s handling of personal information, including how you can seek access to or correction of personal information held about you by CSL please see our Privacy Policy.

Please do not use this form to report adverse events/adverse drug reactions. If you would like to report an adverse event/adverse drug reaction in relation to a CSL product, please visit the ‘Contact Us’ section of this website.